Global, Regional, and National Burden of Children and Adolescents with Acute Lymphoblastic Leukemia from 1990 to 2021: a Systematic Analysis for the Global Burden of Disease Study 2021

Overview

Journal Front Public Health

Specialty Public Health

Date 2025 Feb 13

PMID 39944070

Authors

Lei Wang

Xue Yao

Linhua Yang

Affiliations

Soon will be listed here.

Abstract

Background: Acute lymphoblastic leukemia (ALL) is a common cancer in children and adolescents, severely affecting their survival and health. With the discovery of new drugs and improved treatment options, the survival rate of ALL in children and adolescents has improved significantly.

Methods: We used the GBD (global burden of disease) database to collect patients aged 0-19 years (0-5 years, 5-9 years, 10-14 years, 15-19 years) diagnosed with ALL between 1990 and 2021. Disease status and change were analyzed by learning about the prevalence, death, incidence, DALYs (disability-adjusted life years), percentage change, and the estimated annual percentage change (EAPC).

Results: In 2021, there were 53,485 new cases of childhood and adolescent ALL, 23,991 deaths, and an estimated 1960,922 DALYs. Incidence, deaths and DALYs have declined globally, with only a rise in low-SDI regions. In 2021, middle-SDI regions have the highest cases of prevalence, incidence, deaths, and DALYs, accounting for approximately one-third of the global total. High-SDI regions have the lowest deaths and DALYs. East Asia has the highest prevalence and incidence. Australasia has the lowest death and DALYs. From 1990 to 2021, children and adolescent ALL deaths and DALYs show a declining trend in about 72.5% of countries, with only Sub-Saharan Africa showing an increase. The prevalence of ALL in children and adolescents is higher in males, with the highest cases in patients under 5 years of age.

Conclusion: Our study highlights the trend of decreasing deaths and DALYs of ALL in children and adolescents. However, there is a need to improve healthcare prevention and timely standardized treatment in developing countries and less developed regions.

References

Newman H, Hunger S . Future of Treatment of Adolescents and Young Adults With ALL: A Vision for Collaboration and Equity. J Clin Oncol. 2023; 42(6):665-674. PMC: 11902898. DOI: 10.1200/JCO.23.01351. View

Greaves M . A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018; 18(8):471-484. PMC: 6986894. DOI: 10.1038/s41568-018-0015-6. View

Duffy C, Santana V, Inaba H, Jeha S, Pauley J, Sniderman L . Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol. Implement Sci Commun. 2022; 3(1):62. PMC: 9187890. DOI: 10.1186/s43058-022-00310-5. View

Ahmad I, Ghafoor T, Ullah A, Naz S, Tahir M, Ahmed S . Pediatric Acute Lymphoblastic Leukemia: Clinical Characteristics, Treatment Outcomes, and Prognostic Factors: 10 Years' Experience From a Low- and Middle-Income Country. JCO Glob Oncol. 2023; 9:e2200288. PMC: 10497281. DOI: 10.1200/GO.22.00288. View

Caniza M, Odio C, Mukkada S, Gonzalez M, Ceppi F, Chaisavaneeyakorn S . Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries. Expert Rev Hematol. 2015; 8(5):627-45. DOI: 10.1586/17474086.2015.1071186. View

Haupt S, Caramia F, Klein S, Rubin J, Haupt Y . Sex disparities matter in cancer development and therapy. Nat Rev Cancer. 2021; 21(6):393-407. PMC: 8284191. DOI: 10.1038/s41568-021-00348-y. View

Hayashi H, Makimoto A, Yuza Y . Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective. Cancers (Basel). 2024; 16(4). PMC: 10887299. DOI: 10.3390/cancers16040723. View

Magrath I, Epelman S . Cancer in adolescents and young adults in countries with limited resources. Curr Oncol Rep. 2013; 15(4):332-46. DOI: 10.1007/s11912-013-0327-3. View

Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y . Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020; 9:14. PMC: 7304189. DOI: 10.1186/s40164-020-00170-6. View

10.

Pui C, Evans W . A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013; 50(3):185-96. PMC: 3771494. DOI: 10.1053/j.seminhematol.2013.06.007. View

11.

Li C, Dalvi R, Yonemori K, Ariffin H, Lyu C, Farid M . Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey. ESMO Open. 2019; 4(3):e000467. PMC: 6555609. DOI: 10.1136/esmoopen-2018-000467. View

12.

Ortiz R, Vasquez L, Giri B, Kapambwe S, Dille I, Mahmoud L . Developing and sustaining high-quality care for children with cancer: the WHO Global Initiative for Childhood Cancer. Rev Panam Salud Publica. 2023; 47:e164. PMC: 10729910. DOI: 10.26633/RPSP.2023.164. View

13.

Wang J, Bhakta N, Ayer Miller V, Revsine M, Litzow M, Paietta E . Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing. JCO Precis Oncol. 2022; 6:e2100326. PMC: 9200386. DOI: 10.1200/PO.21.00326. View

14.

Rujkijyanont P, Inaba H . Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries. Leukemia. 2024; 38(8):1649-1662. DOI: 10.1038/s41375-024-02277-9. View

15.

Hunger S, Mullighan C . Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015; 373(16):1541-52. DOI: 10.1056/NEJMra1400972. View

16.

Ceppi F, Antillon F, Pacheco C, Sullivan C, Lam C, Howard S . Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries. Expert Rev Hematol. 2015; 8(5):613-26. DOI: 10.1586/17474086.2015.1049594. View

17.

Pui C, Tang J, Yang J, Chen S, Chen Z . International Collaboration to Save Children With Acute Lymphoblastic Leukemia. J Glob Oncol. 2019; 5:1-2. PMC: 6550034. DOI: 10.1200/JGO.19.00010. View

18.

Abboud M, Ghanem K, Muwakkit S . Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol. 2014; 26(6):650-5. DOI: 10.1097/CCO.0000000000000125. View

19.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-1075. PMC: 5879496. DOI: 10.1016/S0140-6736(17)33326-3. View

20.

Oh B, Lee S, Yeoh A . Curing the Curable: Managing Low-Risk Acute Lymphoblastic Leukemia in Resource Limited Countries. J Clin Med. 2021; 10(20). PMC: 8540602. DOI: 10.3390/jcm10204728. View